AC Immune SA

ACIU69

Penny Stock

$3.38arrow_drop_up2.12%$0.06

Penny Stock

ACIU69

$3.38

arrow_drop_up2.12%$0.06

Penny Stock

Performance History

Key Stats
Open	$3.30
Prev. Close	$3.29
EPS	-0.45
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$334.42M
PE Ratio	-

	LOW	HIGH
Day Range	3.21	3.44
52 Week Range	2.20	5.14

Ratios







EPS	-0.45

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About AC Immune SA (ACIU)

AC Immune SA (ACIU) is a Switzerland-based clinical-stage biopharmaceutical company that focuses on discovering, developing, and commercializing precision medicines for neurodegenerative diseases. The company utilizes its proprietary technology platforms to generate a pipeline of therapeutic candidates that target misfolded proteins implicated in diseases such as Alzheimer's and Parkinson's. ACIU's approach is grounded in a deep understanding of the biology of these diseases, allowing the company to develop therapies that target the underlying causes rather than just the symptoms.

ACIU's lead candidate is a small molecule therapeutic called ACI-24, which is being developed as a potential treatment for Alzheimer's disease. ACI-24 targets a specific form of amyloid-beta (Abeta) protein that is believed to play a key role in the development and progression of Alzheimer's. The company has completed Phase 1b clinical trials for ACI-24, demonstrating encouraging safety and immunogenicity profiles. ACIU is now planning to initiate Phase 2 trials to further evaluate the drug's efficacy and safety in larger patient populations.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Andrea Pfeifer Ph.D.
Headquarters: Lausanne
Employees: 126
Exchange: NASDAQ

Keep an eye on AC Immune SA

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is AC Immune SA's (ACIU) price per share?

The current price per share for AC Immune SA (ACIU) is $3.38. The stock has seen a price change of $0.07 recently, indicating a 2.13% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for AC Immune SA (ACIU)?

For AC Immune SA (ACIU), the 52-week high is $5.14, which is 52.07% from the current price. The 52-week low is $2.2, the current price is 53.64% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is AC Immune SA (ACIU) a growth stock?

AC Immune SA (ACIU) has shown an average price growth of -3.66% over the past three years. It has received a score of 33 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying AC Immune SA as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is AC Immune SA (ACIU) stock price performance year to date (YTD)?

As of the latest data, AC Immune SA (ACIU) has a year-to-date price change of -27.93%. Over the past month, the stock has experienced a price change of 11.18%. Over the last three months, the change has been 9.74%. Over the past six months, the figure is -5.32%. Looking at a longer horizon, the five-year price change stands at -59.33%.

help

Is AC Immune SA (ACIU) a profitable company?

AC Immune SA (ACIU) has a net income of -$54.23M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 28.52% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $14.8M, although specific revenue growth data is currently not available. Operating income is noted at -$53.62M. Furthermore, the EBITDA is -$40.48M.

help

What is the market capitalization of AC Immune SA (ACIU)?

AC Immune SA (ACIU) has a market capitalization of $334.43M. The average daily trading volume is 3.35, indicating the stock's liquidity and investor engagement.